Freeline Therapeutics
Ron Katz has extensive experience in business development and intellectual property. Ron currently holds the positions of VP, Head of Business Development and Intellectual Property, as well as Head of Business Development, at Freeline. Prior to this, they worked at Columbia Technology Ventures for over 15 years, starting as a Senior Technology Licensing Officer and eventually becoming the Associate Director of Manhattanville.
Ron Katz received their Ph.D. from Columbia University, where they attended from 2000 to 2006. Ron then completed their MBA at Columbia Business School from 2006 to 2008.
This person is not in any teams
Freeline Therapeutics
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.